G1 Therapeutics Inc (GTHX)
7.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 18, 16:00
G1 Therapeutics 1 Year Total Returns (Daily)
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
September 18, 2024 | 379.9% |
September 17, 2024 | 364.3% |
September 16, 2024 | 364.3% |
September 13, 2024 | 349.7% |
September 12, 2024 | 332.1% |
September 11, 2024 | 321.9% |
September 10, 2024 | 340.1% |
September 09, 2024 | 340.7% |
September 06, 2024 | 326.9% |
September 05, 2024 | 319.4% |
September 04, 2024 | 319.4% |
September 03, 2024 | 317.1% |
August 30, 2024 | 308.6% |
August 29, 2024 | 306.3% |
August 28, 2024 | 318.8% |
August 27, 2024 | 324.4% |
August 26, 2024 | 324.4% |
August 23, 2024 | 302.3% |
August 22, 2024 | 301.1% |
August 21, 2024 | 290.1% |
August 20, 2024 | 290.1% |
August 19, 2024 | 289.6% |
August 16, 2024 | 299.4% |
August 15, 2024 | 279.7% |
August 14, 2024 | 268.8% |
Date | Value |
---|---|
August 13, 2024 | 261.2% |
August 12, 2024 | 261.7% |
August 09, 2024 | 252.7% |
August 08, 2024 | 249.3% |
August 07, 2024 | 247.8% |
August 06, 2024 | 95.85% |
August 05, 2024 | 82.03% |
August 02, 2024 | 85.98% |
August 01, 2024 | 91.78% |
July 31, 2024 | 78.75% |
July 30, 2024 | 69.79% |
July 29, 2024 | 59.57% |
July 26, 2024 | 64.29% |
July 25, 2024 | 67.37% |
July 24, 2024 | 56.07% |
July 23, 2024 | 58.85% |
July 22, 2024 | 51.03% |
July 19, 2024 | 35.96% |
July 18, 2024 | 43.31% |
July 17, 2024 | 44.26% |
July 16, 2024 | 45.23% |
July 15, 2024 | 34.44% |
July 12, 2024 | 31.28% |
July 11, 2024 | 22.04% |
July 10, 2024 | 16.25% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.15%
Minimum
Oct 09 2023
379.9%
Maximum
Sep 18 2024
-15.66%
Average
-32.32%
Median
1 Year Total Returns (Daily) Benchmarks
PetIQ Inc | -- |
Biomarin Pharmaceutical Inc | -20.06% |
Regeneron Pharmaceuticals Inc | 0.96% |
Verrica Pharmaceuticals Inc | -71.99% |
Terns Pharmaceuticals Inc | 101.5% |